Filing Flows › BillionToOne (BLLN) › Clinical trial support and other services revenue
BillionToOne (BLLN) Clinical trial support and other services revenue by quarter
BillionToOne's Clinical trial support and other services revenue was $1.6M in Q3 2026 (third quarter 2026), +7% from Q2 2026. Over the last 5 quarters it ranged from $761K (Q3 2025) to $1.6M (Q3 2026).
| Quarter | Clinical trial support and other services revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.6M | +7% | +115% |
| Q2 2026 | $1.5M | +34% | — |
| Q1 2026 | $1.1M | +41% | — |
| Q4 2025 | $810K | +6% | — |
| Q3 2025 | $761K | — | — |
Q3 2026 at a glance
BillionToOne, Q3 2026: revenue $123M (+47% year over year), operating margin 9.0%, net earnings $17.4M, operating cash flow $12.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is BillionToOne's Clinical trial support and other services revenue?
BillionToOne's Clinical trial support and other services revenue was $1.6M in Q3 2026 (third quarter 2026), +7% from Q2 2026.
How has BillionToOne's Clinical trial support and other services revenue changed?
Over the last 5 quarters it ranged from $761K (Q3 2025) to $1.6M (Q3 2026).